L1 cell adhesion molecules as regulators of tumor cell invasiveness

Cell Adhesion and Migration

Volumn 3, Issue 3, 2009, Pages 275-277

  Siesser, Priscila F ^a   Maness, Patricia F ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Axon guidance; Cancer; Cancer stem cell; Invasion; L1CAMs; Metastasis; Migration

Indexed keywords

NERVE CELL ADHESION MOLECULE L1; SHORT HAIRPIN RNA;

CANCER INVASION; CANCER RECURRENCE; CELL ADHESION; CELL INVASION; HUMAN; METASTASIS; NONHUMAN; NOTE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STEM CELL; TUMOR CELL;

EID: 68249120305     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.3.3.8689     Document Type: Note

References (30)

1. Schmid RS, Maness PF. L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol 2008: 18:245-250
2. Maness PF, Schachner M. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci 2007; 10:19-26. (Pubitemid 46026522)
3. Rolf B, Lang D, Hillenbrand R, Richter M, Schachner M, Bartsch U. Altered expression of CHL1 by glial cells in response to optic nerve injury and intravitreal application of fibroblast growth factor-2. J Neurosci Res 2003; 71:835-843 (Pubitemid 36293004)
4. Holm J, Hillenbrand R, Steuber V, Bartsch U, Moos M, Lubbert H, et al. Structural features of a close homologue of L1 (CHL1) in the mouse: a new member of the L1 family of neural recognition molecules. Eur J Neurosci 1996; 8:1613-1629 (Pubitemid 126735402)
5. Hillenbrand R, Molthagen M, Montag D, Schachner M. The close homologue of the neural adhesion molecule L1 (CHL1): patterns of expression and promotion of neurite outgrowth by heterophilic interactions. Eur J Neurosci 1999; 11:813-826 (Pubitemid 29106042)
6. Demyanenko GP, Shibata Y, Maness PF. Altered distribution of dopaminergic neurons in the brain of L1 null mice. Brain Res Dev Brain Res 2001; 126:21-30.
7. Demyanenko GP, Schachner M, Anton E, Schmid R, Feng G, Sanes J, Maness PF. Close homolog of L1 modulates area-specific neuronal positioning and dendrite orientation in the cerebral cortex. Neuron 2004; 44:423-437 (Pubitemid 39423345)
8. Tsuzuki T, Izumoto S, Ohnishi T, Hiraga S, Arita N, Hayakawa T. Neural cell adhesion molecule L1 in gliomas: correlation with TGFbeta and p53. J Clin Pathol 1998; 51:13-17 (Pubitemid 28122578)
9. Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev 2002; 16:2058-2072
10. Zecchini S, Bianchi M, Colombo N, Fasani R, Goisis G, Casadio C, et al. The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res 2008; 68:1110-1118 (Pubitemid 351272229)
11. Kaifi JT, Reichelt U, Quaas A, Schurr PG, Wachowiak R, Yekebas EF, et al. L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol 2007; 20:1183-1190 (Pubitemid 47609067)
12. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005; 168:633-642
13. Gast D, Riedle S, Issa Y, Pfeifer M, Beckhove P, Sanderson MP, et al. The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene 2008; 27:1281-1289 (Pubitemid 351294696)
14. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 2008; 68:6043-6048
15. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367:645-648 (Pubitemid 24067706)
16. Soltysova A, Altanerova V, Altaner C. Cancer stem cells. Neoplasma 2005; 52:435-440
17. Sehgal A, Boynton AL, Young RF, Vermeulen SS, Yonemura KS, Kohler EP, et al. Cell adhesion molecule Nr-CAM is overexpressed in human brain tumors. Int J Cancer 1998; 76:451-458 (Pubitemid 28227983)
18. Lukashova-v Zangen I, Kneitz S, Monoranu CM, Rutkowski S, Hinkes B, Vince GH, et al. Ependymoma gene expression profiles associated with histological subtype, proliferation and patient survival. Acta Neuropathol 2007; 113:325-337 (Pubitemid 46443567)
19. Panicker AK, Buhusi M, Erickson A, Maness PF. Endocytosis of beta1 integrins is an early event in migration promoted by the cell adhesion molecule L1. Exp Cell Res 2006; 312:299-307. (Pubitemid 41814839)
20. Mechtersheimer S, Gutwein P, Agmon-Levin N, Stoeck A, Oleszewski M, Riedle S, et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 2001; 155:661-673 (Pubitemid 34289323)
21. Maretzky T, Schulte M, Ludwig A, Rose-John S, Blobel C, Hartmann D, et al. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma- secretase and regulates neural cell adhesion, cell migration and neurite outgrowth. Mol Cell Biol 2005; 25:9040-9053 (Pubitemid 41429092)
22. Wildeboer D, Naus S, Amy Sang QX, Bartsch JW, Pagenstecher A. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J Neuropathol Exp Neurol 2006; 65:516-527 (Pubitemid 44297273)
23. Conacci-Sorrell M, Kaplan A, Raveh S, Gavert N, Sakurai T, Ben-Ze'ev A. The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation. Cancer Res 2005; 65:11605-11612
24. Arlt MJ, Novak-Hofer I, Gast D, Gschwend V, Moldenhauer G, Grunberg J, et al. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 2006; 66:936-943 (Pubitemid 43165961)
25. Knogler K, Grunberg J, Zimmermann K, Cohrs S, Honer M, Ametamey S, et al. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin Cancer Res 2007; 13:603-611 (Pubitemid 46225367)
26. Hart LS, El-Deiry WS. Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells. J Clin Oncol 2008; 26:2901-2910
27. Herman JG, Meadows GG. Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. Int J Oncol 2007; 30:1231-1238
28. Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ, Mercurio AM. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 2003; 63:5230-5233 (Pubitemid 37139833)
29. Muller MW, Giese NA, Swiercz JM, Ceyhan GO, Esposito I, Hinz U, et al. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 2007; 121:2421-2433 (Pubitemid 350022411)
30. Nguyen QD, Rodrigues S, Rodrigue CM, Rivat C, Grijelmo C, Bruyneel E, et al. Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts. Mol Cancer Ther 2006; 5:2070-2077 (Pubitemid 44336579)